These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 6316012)

  • 1. Use of fluoresceinated complement-coated bacteria and sheep erythrocyte-antibody-complement complexes for identification of complement receptors on lymphoid cell lines: differences in binding characteristics between cell lines of normal and malignant origin.
    Benjamin D; Magrath IT; Freeman CB
    J Natl Cancer Inst; 1983 Nov; 71(5):897-902. PubMed ID: 6316012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement receptor expression by neoplastic and normal human cells.
    Gaither TA; Magrath IT; Berger M; Hammer CH; Novikovs L; Santaella M; Frank MM
    J Immunol; 1983 Aug; 131(2):899-905. PubMed ID: 6306108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor promoter 12-O-tetradecanoylphorbol 13-acetate: effect on complement and Epstein-Barr virus receptors in human lymphoblastoid cell lines.
    Yamamoto N; Mitsuma T; Vogt A
    J Natl Cancer Inst; 1982 Mar; 68(3):385-90. PubMed ID: 6278193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of lymphoma-derived cell lines: comparison of cell lines positive and negative for Epstein-Barr virus nuclear antigen. II. Surface markers.
    Magrath IT; Freeman CB; Pizzo P; Gadek J; Jaffe E; Santaella M; Hammer C; Frank M; Reaman G; Novikovs L
    J Natl Cancer Inst; 1980 Mar; 64(3):477-83. PubMed ID: 6243722
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological properties of lymphoblastoid cell lines (UHKT) - 1, 2, 3, 4, 5, 6) established from cases of human leukemias.
    Koubek K; Stockbauer P; Herzog P; Roubal J; Praehová K; Cinátl J; Korínková P; Michalová K
    Czech Med; 1983; 6(3):159-68. PubMed ID: 6315324
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New method for detecting Epstein-Barr virus association in nonproducer lymphoblastoid cell lines.
    Giunta S; Groppa G
    Cancer Res; 1983 Nov; 43(11):5064-7. PubMed ID: 6311404
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of expression of insulin and IGF-I receptor by Epstein-Barr virus and its gene products LMP and EBNA-2 in lymphocyte cell lines.
    Kriauciunas KM; Goldstein BJ; Lipes MA; Kahn CR
    J Cell Physiol; 1993 Mar; 154(3):486-95. PubMed ID: 8382208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surface receptors on human haematopoietic cell lines.
    Huber C; Sundström C; Nilsson K; Wigzell H
    Clin Exp Immunol; 1976 Sep; 25(3):367-76. PubMed ID: 963908
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of complement receptor expression in cell lines derived from human undifferentiated lymphomas. II. Characterization of the induced complement receptors and demonstration of the simultaneous induction of EBV receptor.
    Magrath I; Freeman C; Santaella M; Gadek J; Frank M; Spiegel R; Novikovs L
    J Immunol; 1981 Sep; 127(3):1039-43. PubMed ID: 6267130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of E-and EAC-rosette formation by gentamicin, ampicillin and tetracycline.
    Nualart P; Sen L; Estevez ME; Diez RA
    Biomed Pharmacother; 1985; 39(4):187-91. PubMed ID: 3933589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse red cell receptors on human hematopoietic cell lines.
    Sundström C; Sällström J; Nilsson K
    J Clin Lab Immunol; 1980 Mar; 3(2):99-103. PubMed ID: 7205935
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A rosette assay for the determination of C 1 q receptor-bearing cells.
    Gabay Y; Perlmann H; Perlmann P; Sobel AT
    Eur J Immunol; 1979 Oct; 9(10):797-801. PubMed ID: 118036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue C3b receptors.
    Schrieber L; Penny R
    Clin Exp Immunol; 1979 Nov; 38(2):316-22. PubMed ID: 527266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenotype-related differences in the expression of D-type cyclins in human B cell-derived lines.
    Pokrovskaja K; Ehlin-Henriksson B; Bartkova J; Bartek J; Scuderi R; Szekely L; Wiman KG; Klein G
    Cell Growth Differ; 1996 Dec; 7(12):1723-32. PubMed ID: 8959341
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of complement receptors in human cell lines derived from undifferentiated lymphomas.
    Jaffe ES; Smith SA; Magrath IT; Freeman CB; Alabaster O; Sussman EH
    Lab Invest; 1981 Sep; 45(3):295-301. PubMed ID: 7278135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Guinea pig erythrocyte rosette formation as a nonspecific cell surface receptor assay in the cat.
    Wellman ML; Kociba GJ; Rojko JL
    Am J Vet Res; 1986 Feb; 47(2):433-7. PubMed ID: 3954230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential expression of nucleoskeleton- and cytoskeleton-associated proteins in Burkitt lymphoma-derived and Epstein-Barr virus-immortalized lymphoblastoid cell lines.
    Szekely L; Pokrovskaja K; Klein G
    Cell Growth Differ; 1997 May; 8(5):599-609. PubMed ID: 9149911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of permanent cell lines from patients with acute and hairy cell leukemia.
    Stöckbauer P; Cinátl J; Mach O
    Neoplasma; 1981; 28(4):385-95. PubMed ID: 6270579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement receptors on normal human lymphocytes containing parallel tubular arrays.
    Payne CM; Nagle RB
    Am J Pathol; 1980 Jun; 99(3):645-66. PubMed ID: 6247918
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Functional insulin and insulin-like growth factor-1 receptors are preferentially expressed in multiple myeloma cell lines as compared to B-lymphoblastoid cell lines.
    Freund GG; Kulas DT; Way BA; Mooney RA
    Cancer Res; 1994 Jun; 54(12):3179-85. PubMed ID: 8205537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.